<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-01-10 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-01-10/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-01-10"><meta property="og:description" content="ğŸ“… Daily Report - 2026-01-10 ä»Šæ—¥ç­›é€‰å‡º 34 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-01-10T00:00:00+00:00"><meta property="article:modified_time" content="2026-01-10T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week022026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-01-10"><meta itemprop=description content="ğŸ“… Daily Report - 2026-01-10 ä»Šæ—¥ç­›é€‰å‡º 34 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-01-10T00:00:00+00:00"><meta itemprop=dateModified content="2026-01-10T00:00:00+00:00"><meta itemprop=wordCount content="1898"><meta itemprop=keywords content="Research,Daily,Week022026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-01-10"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-01-10 ä»Šæ—¥ç­›é€‰å‡º 34 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-10</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-01-10T00:00:00Z>2026-01-10</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-01-10>ğŸ“… Daily Report - 2026-01-10</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>34</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯åœ¨ç¥ç»ç³»ç»Ÿç–¾ç—…ï¼ˆå¦‚FUSç›¸å…³ç–¾ç—…ï¼‰å’Œè‚¿ç˜¤ï¼ˆå¦‚ALKé˜³æ€§NSCLCï¼‰ç ”ç©¶ä¸­å±•ç°å‡ºç²¾å‡†å®šä½å’Œæœºåˆ¶è§£æçš„æ½œåŠ›ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢ç–¾ç—…ï¼ˆå¦‚å‰åˆ—è…ºç™Œã€è‚ºç™Œã€ç¥ç»ç³»ç»Ÿç–¾ç—…ï¼‰çš„åˆ†å­æœºåˆ¶ï¼Œèšç„¦åŸºå› è¡¨è¾¾è°ƒæ§ã€ä¿¡å·é€šè·¯å¼‚å¸¸åŠè€è¯æ€§ã€‚</li><li>æ¯”è¾ƒä¸åŒç‰©ç§ï¼ˆå¦‚çŠ¬ã€äººã€çŒªï¼‰çš„è‚¿ç˜¤å¾®ç¯å¢ƒåŠç–¾ç—…æ¨¡å‹ï¼Œå‘ç°ä¿å®ˆçš„æ²»ç–—é¶ç‚¹ã€‚</li><li>è§£æç»†èƒçŠ¶æ€åŠ¨æ€å˜åŒ–ã€åŸºå› ç»„é‡å¡‘ä¸å‘è‚²ï¼ˆå¦‚ç”Ÿæ®–ç»†èƒå‘è‚²ï¼‰åŠç¨³æ€ç»´æŒçš„å…³è”ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å•ç»†èƒå¤–æ˜¾å­åˆ é™¤è°±åˆ†æï¼ˆSingle-Cell Exon Deletion Profilingï¼‰æ­ç¤ºäº†å‰ªæ¥äº‹ä»¶å¯¹åŸºå› è¡¨è¾¾å’Œç»†èƒçŠ¶æ€åŠ¨æ€çš„å½±å“ã€‚</li><li>DRIP-seqå’ŒCHIP-seqç­‰æŠ€æœ¯ç”¨äºè§£æR-loopå¤„ç†æœºåˆ¶ã€åŸºå› ç»„ç»“åˆ/å æœ‰æƒ…å†µåŠç­‰ä½åŸºå› ç‰¹å¼‚æ€§è¡¨è¾¾ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
MD Andersonä¸SOPHiA GENETICSè¾¾æˆæˆ˜ç•¥åˆä½œï¼Œå°†AIåˆ†æä¸RNAæµ‹åºç»“åˆï¼ŒåŠ é€ŸAIé©±åŠ¨çš„ç²¾å‡†è‚¿ç˜¤å­¦ç ”ç©¶ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤åŸºå› ç»„åŠå¤šæ¨¡æ€æ•°æ®åˆ†æï¼Œè½¬åŒ–ä¸ºä¸´åºŠæ´å¯Ÿã€‚</li><li>å•ç»†èƒRNAæµ‹åºæŠ€æœ¯åœ¨ç™Œç—‡ç ”ç©¶ä¸­çš„åº”ç”¨ã€‚</li><li>æ£€æµ‹å•ç»†èƒRNAæµ‹åºä¸­çš„ç­‰ä½åŸºå› åŠ¨åŠ›å­¦ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>SOPHiA GENETICSçš„AIåˆ†æå¹³å°ã€‚</li><li>Parse Biosciencesçš„ç»„åˆæ¡å½¢ç æŠ€æœ¯ã€‚</li><li>ASPENå·¥å…·ï¼Œç”¨äºæ£€æµ‹å•ç»†èƒRNAæµ‹åºä¸­çš„ç­‰ä½åŸºå› ä¸å¹³è¡¡å’Œå˜å¼‚ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (31æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE269377 æˆå¹´å¥åº·å°é¼ å’Œçªå˜å‹ FUS å°é¼ è„Šé«“è½¬å½•ç»„çš„ç©ºé—´ç‰¹å¾åˆ†æ [ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomeã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Diana Piol ; Theo Killian ; Gabriele Partel ; Nikolai Hecker ; Sam Kint ; Katy Vandereyken ; Thierry Voet ; Kristofer Davie ; Stein Aerts ; Alejandro Sifrim ; Sandrine Da CruzSeries Type : OtherOrganism : Mus musculusHere we investigated the spatial transcriptome of the aged mouse spinal cord using 10X Genomics Visium platform. We produced local transcriptomes of the full spinal cord with a resolution of 100 um, characterizing ventral and dorsal horn regions, in addition to grey and white matter regions. With these spatial data, it is possible to explore the spatial transcriptome of the aged mouse spinal cord, extrapolating information on the cellular composition of this tissue.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269377">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE309894 ALKé˜³æ€§éå°ç»†èƒè‚ºç™Œæ—©æœŸå¯¹é˜¿æ¥æ›¿å°¼è€è¯çš„ä¸´åºŠç‰¹å¾å’Œç©ºé—´è½¬å½•ç»„åˆ†æï¼šä¸€é¡¹å›é¡¾æ€§OLCSGç ”ç©¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€spatialã€transcriptome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tadahiro Kuribayashi ; Go Makimoto ; Kadoaki Ohashi ; Shuta TomidaSeries Type : OtherOrganism : Homo sapiensIn anaplastic lymphoma kinase (ALK) gene rearrangements positive lung cancer, alectinib has shown good efficacy and is used as a first-line drug. However, some cases show early resistance within 3 months, but the characteristics of these cases have not been established. We analyzed patients with unresectable stage III/IV without indications for radical radiotherapy and recurrent ALK-positive lung cancer who received alectinib for primary ALK-TKI. Spatial transcriptome analysis and immunohistochemical staining revealed upregulation of Annexin A1 (ANXA1) in the early resistant group.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309894">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE306114 å‰åˆ—è…ºç™Œç­‰ä½åŸºå› ç‰¹å¼‚æ€§è¡¨è¾¾å›¾è°±æ­ç¤ºäº† AR ä¿¡å·ä¼ å¯¼å’Œè€è¯é€šè·¯ä¸­åå¤å‡ºç°çš„ã€é˜¶æ®µç‰¹å¼‚æ€§çš„äº‹ä»¶ [ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€ChIP-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Margaret Tsui ; Rebecca ChenSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe effects of cis-regulatory alterations in prostate cancer (PCa) are insufficiently characterized, presenting an opportunity to discover driver genes and therapeutic targets. To comprehensively study these effects, we identify genes undergoing allele-specific expression (ASE) in localized PCa and metastatic castration-resistant PCa (mCRPC) samples. By defining recurrent ASE events across prostate tissue and tumor-enriched ASE, we develop CASEDI, a computational framework for prioritizing cancer drivers by integrating ASE and clinical data. CASEDI reveals genes showing recurrent ASE and altered expression in PCa, including AR-regulated and oncogenic ACSM1. mCRPC samples show enrichment of ASE in DNA repair, resistance pathways, and oncogenes and increased frequency of monoallelic expression (MAE) compared to localized tumors. We define an mCRPC gene signature based on MAE status that identifies a subgroup of localized patients with worse prognosis. Using ASE analysis, we expand the landscape of cis-regulatory events in PCa to inform the identification of additional therapeutic targets.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306114">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE306113 å‰åˆ—è…ºç™Œç­‰ä½åŸºå› ç‰¹å¼‚æ€§è¡¨è¾¾å›¾è°±æ­ç¤ºäº† AR ä¿¡å·ä¼ å¯¼å’Œè€è¯é€šè·¯ä¸­åå¤å‡ºç°çš„ã€é˜¶æ®µç‰¹å¼‚æ€§çš„äº‹ä»¶ [RNA-Seq 2]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Margaret Tsui ; Rebecca ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe effects of cis-regulatory alterations in prostate cancer (PCa) are insufficiently characterized, presenting an opportunity to discover driver genes and therapeutic targets. To comprehensively study these effects, we identify genes undergoing allele-specific expression (ASE) in localized PCa and metastatic castration-resistant PCa (mCRPC) samples. By defining recurrent ASE events across prostate tissue and tumor-enriched ASE, we develop CASEDI, a computational framework for prioritizing cancer drivers by integrating ASE and clinical data. CASEDI reveals genes showing recurrent ASE and altered expression in PCa, including AR-regulated and oncogenic ACSM1. mCRPC samples show enrichment of ASE in DNA repair, resistance pathways, and oncogenes and increased frequency of monoallelic expression (MAE) compared to localized tumors. We define an mCRPC gene signature based on MAE status that identifies a subgroup of localized patients with worse prognosis. Using ASE analysis, we expand the landscape of cis-regulatory events in PCa to inform the identification of additional therapeutic targets.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306113">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE306112 å‰åˆ—è…ºç™Œç­‰ä½åŸºå› ç‰¹å¼‚æ€§è¡¨è¾¾å›¾è°±æ­ç¤ºäº† AR ä¿¡å·ä¼ å¯¼å’Œè€è¯é€šè·¯ä¸­åå¤å‡ºç°çš„ã€é˜¶æ®µç‰¹å¼‚æ€§çš„äº‹ä»¶ [RNA-Seq 1]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Margaret Tsui ; Lorraine NunizSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe effects of cis-regulatory alterations in prostate cancer (PCa) are insufficiently characterized, presenting an opportunity to discover driver genes and therapeutic targets. To comprehensively study these effects, we identify genes undergoing allele-specific expression (ASE) in localized PCa and metastatic castration-resistant PCa (mCRPC) samples. By defining recurrent ASE events across prostate tissue and tumor-enriched ASE, we develop CASEDI, a computational framework for prioritizing cancer drivers by integrating ASE and clinical data. CASEDI reveals genes showing recurrent ASE and altered expression in PCa, including AR-regulated and oncogenic ACSM1. mCRPC samples show enrichment of ASE in DNA repair, resistance pathways, and oncogenes and increased frequency of monoallelic expression (MAE) compared to localized tumors. We define an mCRPC gene signature based on MAE status that identifies a subgroup of localized patients with worse prognosis. Using ASE analysis, we expand the landscape of cis-regulatory events in PCa to inform the identification of additional therapeutic targets.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306112">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE299441 æˆŠç³–ç£·é…¸é€”å¾„çš„ç³–é…µè§£æ—è·¯æ˜¯ç¥ç»ç³»ç»Ÿæ„Ÿè§‰ç¨³æ€å’Œè½´çªå†ç”Ÿçš„ä»£è°¢æ£€æŸ¥ç‚¹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€nervousã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yayue Song ; Simone Di GiovanniSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHomeostasis and repair in the nervous system are thought to rely on distinct molecular programs. Here, we uncover an unexpected role for the pentose phosphate pathway (PPP) in peripheral sensory axons, where it supports both homeostatic mechanosensation and injury-induced axonal regeneration. We show that the PPP is enriched and active in sciatic nerve axoplasms, where it maintains redox balance via NADPH production, enabling normal mechanical sensation. Following sciatic nerve injury, the PPP is required for regeneration by fueling ribonucleotide synthesis through ribose-5-phosphate production. In contrast, this pathway remains inactive after spinal cord injury (SCI), contributing to regenerative failure. Reactivation of the PPP, through neuronal transketolase overexpression or oral ribose supplementation, promotes metabolic reprogramming, restores sensory and motor axonal growth, and improves neurological recovery after SCI. These findings reveal a dual role for the PPP as metabolic rheostat in sensory neuron physiology and regeneration and highlight its therapeutic potential for central nervous system repair.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299441">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE313593 çŠ¬å’Œäººéª¨è‚‰ç˜¤çš„å¤§è§„æ¨¡æ¯”è¾ƒåˆ†ææ­ç¤ºäº†ä¿å®ˆçš„ä¸´åºŠç›¸å…³è‚¿ç˜¤å¾®ç¯å¢ƒäºšå‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€tumor microenvironment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Sushant Patkar ; Joshua Mannheimer ; Stephanie A Harmon ; Christina J Ramirez ; Christina N Mazcko ; Peter L Choyke ; Gregory T Brown ; Baris Turkbey ; Amy K LeBlanc ; Jessica A BeckSeries Type : Expression profiling by arrayOrganism : Canis lupus familiarisAnalyze clinically annotated bulk tumor transcriptomic datasets of canine and patients with human osteosarcoma to identify potentially conserved patterns of disease progression</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313593">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE293013 å•ç»†èƒå¤–æ˜¾å­ç¼ºå¤±åˆ†ææ­ç¤ºäº†å½±å“åŸºå› è¡¨è¾¾å’Œç»†èƒçŠ¶æ€åŠ¨æ€çš„å‰ªæ¥äº‹ä»¶ [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bandana Kumari ; Arun P Damodaran ; Wilfried Guiblet ; Mei-Sheng Xiao ; Amit K Behera ; Tyler On ; Carl Mcintosh ; Maxwell Teszler ; Chelsee Holloway ; Sandra Le ; Nikhil Parab ; Yongmei Zhao ; Michael Aregger ; Thomas Gonatopoulos-PournatzisSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAlternative splicing is a pervasive gene regulatory mechanism critical for diversifying the human proteome. To systematically investigate its role in cell fate determination, we developed scCHyMErA-Seq, a scalable CRISPR-based exon deletion screening platform integrated with 10x Genomics single-cell transcriptomic readouts. This tool enables efficient exon deletion while simultaneously capturing Cas9/Cas12a guides and polyadenylated transcripts at single-cell resolution. Applying scCHyMErA-Seq to high-throughput profiling of alternative cassette exons, we identified numerous exons with strong regulatory effects on gene expression. Analysis of NRF1 alternative exon-7 revealed that this exon modulates NRF1 transcriptional activity by regulating its recruitment to the promoters of target genes. Importantly, gene expression profiles generated using scCHyMErA-Seq accurately recapitulate findings from traditional, labor-intensive orthogonal methods, while offering enhanced scalability and efficiency. Overall, scCHyMErA-Seq represents a robust and versatile platform for systematically unraveling the functional impact of alternative splicing by directly linking specific splicing variants to transcriptional phenotypes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293013">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE292984 å•ç»†èƒå¤–æ˜¾å­ç¼ºå¤±åˆ†ææ­ç¤ºäº†å½±å“åŸºå› è¡¨è¾¾å’Œç»†èƒçŠ¶æ€åŠ¨æ€çš„å‰ªæ¥äº‹ä»¶ [ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šChIP-seqã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bandana Kumari ; Arun P Damodaran ; Wilfried Guiblet ; Mei-Sheng Xiao ; Amit K Behera ; Tyler On ; Carl Mcintosh ; Maxwell Teszler ; Chelsee Holloway ; Sandra Le ; Nikhil Parab ; Yongmei Zhao ; Michael Aregger ; Thomas Gonatopoulos-PournatzisSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensAlternative splicing is a pervasive gene regulatory mechanism critical for diversifying the human proteome. To systematically investigate its role in cell fate determination, we developed scCHyMErA-Seq, a scalable CRISPR-based exon deletion screening platform integrated with 10x Genomics single-cell transcriptomic readouts. This tool enables efficient exon deletion while simultaneously capturing Cas9/Cas12a guides and polyadenylated transcripts at single-cell resolution. Applying scCHyMErA-Seq to high-throughput profiling of alternative cassette exons, we identified numerous exons with strong regulatory effects on gene expression. Analysis of NRF1 alternative exon-7 revealed that this exon modulates NRF1 transcriptional activity by regulating its recruitment to the promoters of target genes. Importantly, gene expression profiles generated using scCHyMErA-Seq accurately recapitulate findings from traditional, labor-intensive orthogonal methods, while offering enhanced scalability and efficiency. Overall, scCHyMErA-Seq represents a robust and versatile platform for systematically unraveling the functional impact of alternative splicing by directly linking specific splicing variants to transcriptional phenotypes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292984">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE269707 æˆå¹´å¥åº·å°é¼ å’Œçªå˜å‹FUSå°é¼ è¿åŠ¨å’Œéè¿åŠ¨ä½“ç»†èƒåŠè½´çªè½¬å½•ç»„çš„ç©ºé—´ç‰¹å¾åˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€transcriptome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Diana Piol ; Theo Killian ; Maria Georgopoulou ; Alejandro Sifrim ; Sandrine Da CruzSeries Type : OtherOrganism : Mus musculusHere we investigated the transcriptome of motor and non-motor axons and cell bodies in the context of mutant FUS-related amyotrophic lateral sclerosis (ALS). We applied Nanostring GeoMX Digital Spatial Profiler platform to profile the transcriptome of subcellular compartments in the lower motor circuitry of a mouse model ricapitulating ALS motor symptoms. This work sheds light for the first time on the transcriptomic alterations in axons and in somas which may contribute to axonal degeneration and neuromuscular junction denervation, early features of ALS.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269707">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 21 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> <strong>MDå®‰å¾·æ£®ç™Œç—‡ä¸­å¿ƒå’ŒSOPHiA GENETICSå®£å¸ƒå»ºç«‹æˆ˜ç•¥åˆä½œå…³ç³»ï¼Œä»¥åŠ é€Ÿäººå·¥æ™ºèƒ½é©±åŠ¨çš„ç²¾å‡†è‚¿ç˜¤å­¦å‘å±•ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šoncologyã€regex:onco(logy|logist|gene|genic)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šMD Anderson and SOPHiA GENETICS are combining AI analytics with RNA sequencing to accelerate precision oncology by translating complex genomic and multimodal data into actionable clinical insights&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/md-anderson-and-sophia-genetics-announce-strategic-collaboration-to-accelerate-ai-driven-precision-oncology/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ç™Œç—‡ç ”ç©¶äººå‘˜å¯ç”³è¯·å•ç»†èƒç ”ç©¶èµ„åŠ©</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šJoin this online info session on January 15 at 8:00 AM Pacific to learn how Parse Biosciencesâ€™ combinatorial barcoding enables cancer research, what the grant includes, and how to apply&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/single-cell-grant-available-for-cancer-researchers/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>ASPENâ€”â€”å•ç»†èƒRNAæµ‹åºä¸­ç­‰ä½åŸºå› åŠ¨æ€çš„ç¨³å¥æ£€æµ‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šASPEN enhances RNA sequencing analyses to detect allelic imbalance and variance in single cells, revealing regulatory control differences in essential, neurodevelopmental, and immune genes&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/aspen-robust-detection-of-allelic-dynamics-in-single-cell-rna-seq-2/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>8</td></tr><tr><td>cancer</td><td>7</td></tr><tr><td>single-cell</td><td>5</td></tr><tr><td>genome</td><td>4</td></tr><tr><td>resistance</td><td>4</td></tr><tr><td>transcriptome</td><td>4</td></tr><tr><td>spatial</td><td>3</td></tr><tr><td>tumor</td><td>2</td></tr><tr><td>scRNA</td><td>2</td></tr><tr><td>ChIP-seq</td><td>2</td></tr><tr><td>cardiac</td><td>2</td></tr><tr><td>transcriptomics</td><td>2</td></tr><tr><td>oncology</td><td>1</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>tumor microenvironment</td><td>1</td></tr><tr><td>RNAseq</td><td>1</td></tr><tr><td>spatial transcriptomics</td><td>1</td></tr><tr><td>immune</td><td>1</td></tr><tr><td>sequencing</td><td>1</td></tr><tr><td>metabolic</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (21æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262252">GSE262252 APOBEC3Aã€APOBEC3B å’Œ APOBEC3H å•å€å‹ I åœ¨ä¹³è…ºç™Œå°é¼ å¼‚ç§ç§»æ¤æ¨¡å‹ä¸­å¯¹è‚¿ç˜¤è¿›å±•çš„ä¸åŒå½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315576">GSE315576 æ ¸ä»æ‰©å¼ é©±åŠ¨ç™Œç—‡ä¸­çš„ä¸‰ç»´åŸºå› ç»„é‡ç»„å’Œè½¬å½•æŠ‘åˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304507">GSE304507 èµ–æ°¨é…¸ä¹³é…¸åŒ–è°ƒèŠ‚çŠ¬è¡€ç®¡è‚‰ç˜¤åœ¨è‘¡è„ç³–é¥¥é¥¿æ¡ä»¶ä¸‹çš„ ATF4 ä»‹å¯¼çš„åº”æ¿€ååº” [RNAseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298402">GSE298402 RNA-Seq åˆ†æ Trim28 ç¼ºå¤±çš„ NPp53 å°é¼ å‰åˆ—è…ºç»„ç»‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292988">GSE292988 å•ç»†èƒå¤–æ˜¾å­ç¼ºå¤±åˆ†ææ­ç¤ºäº†å½±å“åŸºå› è¡¨è¾¾å’Œç»†èƒçŠ¶æ€åŠ¨æ€çš„å‰ªæ¥äº‹ä»¶ [RNA-seq_Rescue_exp]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292986">GSE292986 å•ç»†èƒå¤–æ˜¾å­ç¼ºå¤±åˆ†ææ­ç¤ºäº†å½±å“åŸºå› è¡¨è¾¾å’Œç»†èƒçŠ¶æ€åŠ¨æ€çš„å‰ªæ¥äº‹ä»¶ [RNA-seq_BaseEditor]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283548">GSE283548 åå™¬è¿‡ç¨‹ä¸­ Notch çš„æŠ‘åˆ¶å¯é˜»æ­¢å·¨å™¬ç»†èƒçš„ç‚ç—‡æåŒ– [RNA-seq.å°é¼ ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283547">GSE283547 åå™¬è¿‡ç¨‹ä¸­ Notch çš„æŠ‘åˆ¶å¯é˜»æ­¢å·¨å™¬ç»†èƒçš„ç‚ç—‡æåŒ– [RNA-seq.HumanMouse]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272501">GSE272501 ç”Ÿæ®–ç»†èƒé…å­å‘ç”Ÿè¿‡ç¨‹ä¸­åŸºå› ç»„ç»„ç»‡çš„å…¨å±€æ€§é‡å¡‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245135">GSE245135 é’ è‚Œé†‡å…±è½¬è¿è›‹ç™½-1 (SMIT1) ä¿ƒè¿›å‹åŠ›è¶…è´Ÿè·å°é¼ å¿ƒè„çš„å¿ƒè‚Œè‚¥å¤§å’Œçº¤ç»´åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307045">GSE307045 å°é¼ é»‘ç´ ç»†èƒçš„ç‰¹å¾åˆ†ææ­ç¤ºäº†å†…è€³åŠŸèƒ½çš„è¶…å¾®ç»“æ„å’Œå…ç–«å­¦è§è§£ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300400">GSE300400 å¹²æ‰°ç´ Î³åœ¨çŒªæ—©æœŸå¦Šå¨ æœŸé—´å¯¹å­å®«å†…è†œå…ç–«å¾®ç¯å¢ƒçš„ç¼–ç¨‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271977">GSE271977 çŒªé—´å……è´¨å¹²ç»†èƒå…‹éš†çš„æ‰¹é‡RNAæµ‹åºï¼Œè¿™äº›å…‹éš†å…·æœ‰é«˜æˆ–ä½çš„è„‚è‚ªç”Ÿæˆèƒ½åŠ›</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269749">GSE269749 é€šè¿‡å†…åˆ‡å’Œå¤–åˆ‡å¶è”æ¨¡å¼é«˜æ•ˆå¤„ç†å¹¿æ³›å­˜åœ¨çš„Rç¯å¯é˜²æ­¢åŸºå› ç»„ä¸ç¨³å®š</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253653">GSE253653 DRIP-seq æ­ç¤º REXO4 å’Œ RNaseH1 å…±åŒä½œç”¨ï¼Œå¤„ç†åŸºå› ç»„åŒä¸€åŸºå› ç»„åŒºåŸŸä¸­çš„ R ç¯ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315982">GSE315982 DAXX æ§åˆ¶å°é¼ ç²¾å­å‘ç”Ÿè¿‡ç¨‹ä¸­ LINE1 çš„æ²‰é»˜ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309333">GSE309333 å•æ ¸è½¬å½•ç»„å­¦æ­ç¤ºäº†å°é¼ å‰ç¥ç»èƒ¶è´¨ç˜¤è¿›å±•è¿‡ç¨‹ä¸­ç»†èƒå‘¨æœŸæ§åˆ¶å’Œçªè§¦é€šè·¯å¤±è°ƒã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302146">GSE302146 è¯±å¯¼å¤šèƒ½å¹²ç»†èƒæ¥æºçš„èœ•è†œè‡ªç„¶æ€ä¼¤ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299592">GSE299592 APEX-seq ç»˜åˆ¶æ´»ç»†èƒä¸­è½¬å½•ç»„èŒƒå›´çš„äºšç»†èƒ RNA å®šä½å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291215">GSE291215 åˆ©ç”¨SARS-CoV-2æ„ŸæŸ“è€å¹´å’Œæˆå¹´å°é¼ è‚ºç»†èƒè¿›è¡Œå•ç»†èƒåŸºå› è¡¨è¾¾åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE236762">GSE236762 å¥¥å¸Œæ›¿å°¼è¯±å¯¼å°é¼ å¿ƒè„åŠŸèƒ½éšœç¢çš„å•æ ¸è½¬å½•ç»„åˆ†æ</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-09 21:39</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week022026/ rel=tag>Week022026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-01-09/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-09</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-01-11/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-11</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-23/>ç§‘ç ”æ—¥æŠ¥ 2026-02-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-22/>ç§‘ç ”æ—¥æŠ¥ 2026-02-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-21/>ç§‘ç ”æ—¥æŠ¥ 2026-02-21</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-20/>ç§‘ç ”æ—¥æŠ¥ 2026-02-20</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-19/>ç§‘ç ”æ—¥æŠ¥ 2026-02-19</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (116)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (116)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>